1. bookVolume 59 (2012): Issue Supplement-VI (January 2012)
    Clinical Pharmacy in the Slovak Republic, dedicated to the associated professor Lívia Magulová, PhD.
Journal Details
License
Format
Journal
First Published
25 Nov 2011
Publication timeframe
2 times per year
Languages
English
Copyright
© 2020 Sciendo

Orphan drugs used for treatment in pediatric patients in the slovak republic

Published Online: 19 Jun 2012
Page range: 28 - 34
Journal Details
License
Format
Journal
First Published
25 Nov 2011
Publication timeframe
2 times per year
Languages
English
Copyright
© 2020 Sciendo

Due to the enormous success of scientific research in the field of paediatric medicine many once fatal children's diseases can now be cured. Great progress has also been achieved in the rehabilitation of disabilities. However, there is still a big group of diseases defined as rare, treatment of which has been traditionally neglected by the drug companies mainly due to unprofitability.

Keywords

Orphan drugs and rare diseases at glance Available at http://www.ema.europa.eu/docs/en_GB/document_library/Other/2010/01/WC500069805.pdfSearch in Google Scholar

Hoppu, K.: Paediatric clinical pharmacology - at the beginning of new era, Eur J Clin Pharmacol, 2008, 64, p. 201-205Search in Google Scholar

Regulation (EC) No 141/2000 of the European parliament and of the council. Off J Eur Commun, 43, 2000, L18, p. 1-5.Search in Google Scholar

Regulation (EC) No 847/2000, Off J EurCommun, 43, 2000, L103, p. 5-8.Search in Google Scholar

Regulation (EC) No 1901/2006 of the European Parliament and of the Council;on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004- of 12 December 2006. available at http://ec.europa.eu/health/files/eudralex/vol1/reg_2006_1901/reg_2006_1901_en.pdfSearch in Google Scholar

The Ministry of Health Slovakia Website. http://www.health.gov.sk/?zoznam-kategorizovanych-liekovhttp://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/orphan_search.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d12b&startLetter=View%20all&keyword=Enter%20keywords&searchType=Active%20Substance&jsenabled=true&alreadyLoaded=true&status=Positive&pageNo=3Search in Google Scholar

http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=WC0b01ac058001d124&searchTab=searchByAuthType&alreadyLoaded=true&isNewQuery=true&status=Authorised&keyword=Enter+keywords&searchType=name&taxonomyPath=&treeNumber=&searchGenericType=orphanSearch in Google Scholar

WESTERMARK, K. et al.: European regulation on orphan medicinal products: 10 years of experience and future perspectives. Nature Rev Drug Discov. 2011;10:341-349Search in Google Scholar

KUŽELOVÁ, M.: Does European "orphan" medicinal products legislation help to treat children suffering from rare diseases? (in slovak) Pediatria pre prax. 8, 5, 2007, p. 260-262Search in Google Scholar

KUŽELOVÁ, M. - REPICKÁ, L. - ONDRIAŠOVÁ, E. - KOVÁCSOVÁ, B. - MAZÁG, J. -FOLTÁNOVÁ, T.: Is early treatment of patients with rare diseases in Slovak republic really available? (in slovak) Farm Obzor, 79, 8, 2010, p. 223-227.Search in Google Scholar

The State Institute for Drug Control Website http://www.sukl.sk/sk/databazy-a-servis/databazy/vyhladavanie-v-databaze-registrovanych-liekov?page_id=242&lie_nazov=&lie_kod=&atc_kod=&lie_rc=&atc_nazov=&isk_kod=0&drz_kod=&vyd_kod=0&org_kod=0&reg_typ_kod=EUO&in_kat=INNER&ped_ind=ALL&ped_kontraind=ALLSearch in Google Scholar

http://ec.europa.eu/pharmaforum/docs/pricing_orphans_en.pdfSearch in Google Scholar

Plan your remote conference with Sciendo